Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The central involvement of estrogen in the development of the mammary gland and in the genesis of breast cancer has lent impetus to studies of the links between estrogen action and the cell cycle machinery. Recent studies of the estrogenic regulation of molecules with known roles in the control of G1/S phase progression have resulted in significant advances in understanding these links. Estrogens independently regulate the expression and function of c-Myc and cyclin D1 and the induction of either c-Myc or cyclin D1 is sufficient to recapitulate the effects of estrogen on cell cycle progression. These pathways converge at the activation of cyclin E-Cdk2 complexes. The active cyclin E-Cdk2 complexes are depleted of the cyclin dependent kinase (CDK) inhibitor p21(WAF1/CIP1) because of estrogen-mediated inhibition of nascent p21(WAF1/CIP1). Insulin and estrogen synergistically stimulate cell cycle progression, and the ability of estrogen to antagonize an insulin-induced increase in p21(WAF1/CIP1) gene expression appears to underlie this effect. Antiestrogen treatment of MCF-7 cells leads to an acute decrease of c-Myc expression, a subsequent decline in cyclin D1, and ultimately arrest of cells in a state with features characteristic of quiescence. An antisense-mediated decrease in c-Myc expression results in decreased cyclin D1 expression and inhibition of DNA synthesis, mimicking the effects of antiestrogen treatment and emphasizing the importance of c-Myc as an estrogen/antiestrogen target. These data identify c-Myc, cyclin D1, p21(WAF1/CIP1) and cyclin E-Cdk2 as central components of estrogen regulation of cell cycle progression and hence as potential downstream targets that contribute to the role of estrogen in oncogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Estrogen receptor activation promotes cell proliferation in estrogen‐responsive tissues (breast and endometrium) [435].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [435]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wong, C.-W., McNally, C., Nickbarg, E., Komm, B. S., & Cheskis, B. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192569699 · Cited by 324
RetractedCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01014-0 · Cited by 2,030
Connections and Regulation of the Human Estrogen Receptor
McDonnell, D. P., & Norris, J. D. (2002) · Science · doi:10.1126/science.1071884 · Cited by 579
The myc Oncogene: arvelouslomplex
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84004-0 · Cited by 463
Prall, O. J., Sarcevic, B., Musgrove, E. A., Watts, C. W., & Sutherland, R. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10882 · Cited by 444
Self-citationOpposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression
Liu, M.-M., Albanese, C., Anderson, C. M., Hilty, K., Webb, P., Uht, R. M., Price, R. H., Pestell, R. G., & Kushner, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201829200 · Cited by 422
Myc represses the p21 (WAF1/CIP1) promoter and interacts with Sp1/Sp3
Gartel, A. L., Ye, X., Goufman, E., Shianov, P., Hay, N., Najmabadi, F., & Tyner, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081074898 · Cited by 417
Rapid Actions of Steroid Receptors in Cellular Signaling Pathways
Cato, A. C. B., Nestl, A., & Mink, S. (2002) · Science's STKE · doi:10.1126/stke.2002.138.re9 · Cited by 369
Research works printed but not linked: 1
- Lai A, Sarcevic B, Prall OW & Sutherland RL 2001 Insulin/IGF-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21 WAF1/Cip1 . Journal of Biological Chemistry 276 25823-25833.
Cited by
Items 201–300 of 337
Depletion of c-Myc Inhibits Human Colon Cancer Colo 320 Cells' Growth
Hongxing, Z., Nancai, Y., Wen, S., Guofu, H., Wu, Y., Hanju, H., Liu, Q., Ma, W., Yan-dong, Y., & Huang, H. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.0441 · Cited by 19
Reinbothe, S., Larsson, A.-M., Vaapil, M., Wigerup, C., Sun, J., Jögi, A., Neumann, D., Rönnstrand, L., & Påhlman, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.165 · Cited by 18
Zhou, X., Liu, J., Ye, X., Wang, W., & Xiong, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s12-s6 · Cited by 17
Expression and clinicopathological significance of AOC4P, PRNCR1, and PCAT1 lncRNAs in breast cancer
Abdollahzadeh, R., Mansoori, Y., Azarnezhad, A., Daraei, A., Paknahad, S., Mehrabi, S., Tabei, K., Jafari, D., Shakoori, A., & Tavakkoly‐Bazzaz, J. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.153131 · Cited by 16
Body Microbiota and Its Relationship With Benign and Malignant Breast Tumors: A Systematic Review
Samkari, A., Alsulami, M., Bataweel, L. A., Altaifi, R., Altaifi, A., Saleem, A., Farsi, A., Iskanderani, O. F., Akeel, N. Y., Malibary, N., et al. (2022) · Cureus · doi:10.7759/cureus.25473 · Cited by 19
Influence of fatty acid diets on gene expression in rat mammary epithelial cells
Medvedovic, M., Gear, R., Freudenberg, J., Schneider, J., Bornschein, R. L., Yan, M., Mistry, M. J., Hendrix, H., Karyala, S., Halbleib, D., et al. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.00007.2009 · Cited by 17
Roy, J. W., Cowley, E. A., Blay, J., & Linsdell, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00557.x · Cited by 19
Role of ER-α36 in breast cancer by typical xenoestrogens
Liu, J., Xu, Z., Ma, X., Huang, B., & Pan, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-4006-x · Cited by 15
Furuta, C., Suzuki, A. K., Watanabe, G., Li, C., Taneda, S., & Taya, K. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.02.027 · Cited by 15
Plourde, M., Manhès, C., Leblanc, G., Durocher, F., Dumont, M., Sinilnikova, O. M., Brcas, I., & Simard, J. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0101 · Cited by 15
Vanneste, M., Hanoux, V., Bouakka, M., & Bonnamy, P. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.046 · Cited by 15
Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells
Montenegro, M. F., Collado-González, M., Fernández-Pérez, M. P., Hammouda, M. B., Tolordava, L., Gamkrelidze, M., & Rodríguez‐López, J. N. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-539 · Cited by 14
Mishra, R., Tiwari, A., Bhadauria, S., Mishra, J., Murthy, P. K., & Murthy, P. S. R. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.03.029 · Cited by 14
OGG1 in Lung—More than Base Excision Repair
Ma, X., Ming, H., Liu, L., Zhu, J., Pan, L., Chen, Y., & Xiang, Y. (2022) · Antioxidants · doi:10.3390/antiox11050933 · Cited by 15
Fania, C., Anastasia, L., Vasso, M., Papini, N., Capitanio, D., Venerando, B., & Gelfi, C. (2009) · Electrophoresis · doi:10.1002/elps.200800800 · Cited by 12
Pita, J. M. G., Raspé, E., Coulonval, K., Decaussin‐Petrucci, M., Tarabichi, M., Dom, G., Libert, F., Craciun, L., Andry, G., Wicquart, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1247542 · Cited by 12
RETRACTED ARTICLE: Anti-cancer activity of human gastrointestinal bacteria
Quazi, S. (2022) · Medical Oncology · doi:10.1007/s12032-022-01771-3 · Cited by 12
RetractedHigh-Throughput Identification, Modeling, and Analysis of Cancer Driver Genes In Vivo
Tang, Y. J., Shuldiner, E. G., Karmakar, S., & Winslow, M. M. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041382 · Cited by 14
Elucidating the roles of the mammary and gut microbiomes in breast cancer development
Hoskinson, C., Jiang, R., & Stiemsma, L. T. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1198259 · Cited by 13
Gulliver, L., & Hurst, P. R. (2012) · Steroids · doi:10.1016/j.steroids.2012.02.015 · Cited by 12
Furth, P. A., Wang, W., Kang, K., Rooney, B. L., Keegan, G., Muralidaran, V., Zou, X., & Flaws, J. A. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.09.007 · Cited by 11
Bafor, E. E., Ukpebor, F., Elvis‐Offiah, U. B., Uchendu, A. P., Omoruyi, O., & Omogiade, G. U. (2019) · Journal of Medicinal Food · doi:10.1089/jmf.2019.0155 · Cited by 10
Schlotz, N., Kim, G.-J., Jäger, S., Günther, S., & Lamy, E. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.08.017 · Cited by 11
Khalid, S., Hanif, R., Jabeen, I., Mansoor, Q., & Ismail, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196312 · Cited by 10
An overview on breast cancer genetics and recent innovations: Literature survey
Sree, P. R. R., & Thoppil, J. E. (2021) · Breast Disease · doi:10.3233/bd-201040 · Cited by 9
Del’haye, G. G., Nulmans, I., Bouteille, S. P., Sermon, K., Wellekens, B., Rombaut, M., Vanhaecke, T., Heyden, Y. V., & Kock, J. D. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03351-w · Cited by 10
Estrogen Induces Vav1 Expression in Human Breast Cancer Cells
Du, M., Chen, X., Zhou, X., Wan, Y.-J., Lan, B., Zhang, C., & Cao, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099052 · Cited by 10
Mittal, R., Chaudhry, N., Pathania, S., & Mukherjee, T. K. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666141126121240 · Cited by 9
Cao, M., Niu, Q., Xinyu, X., Yuan, C., Iqbal, T., Huang, Y.-W., Tian, M., Zhao, Z., Li, C., & Zhou, X. (2020) · Biomolecules · doi:10.3390/biom10121645 · Cited by 9
Nucleolin – Characteristics of Protein and its Role in Biology of Cancers and Viral Infections
Masiuk, M. (2008) · Postepy Biologii Komorki · doi:10.2478/v10052-008-0003-1 · Cited by 8
van Leeuwen, J. P. T. M., van der Eerden, B. C. J., van de Peppel, J., Stein, G. S., & Lian, J. B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00009-1 · Cited by 12
Masiuk, M., Urasińska, E., & Domagała, W. (2007) · PubMed · Cited by 7
Proliferative Properties of 17β‐aminoestrogens in MCF ‐7 Human Breast Cancer Cells
Lemini, C., Ávila, M. E., Medina, M., Sánchez, C., Figueroa, A., García-Mondragón, M. J., Vargas‐Vázquez, A., & Jiménez-Orozco, F. A. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12674 · Cited by 7
Probiotics for Prophylaxis and Management of Breast Cancer: Preclinical and Clinical Evidence
Ranjbar, S., Seyednejad, S. A., Zakeri, S. E., Rezaeizadeh, H., & Rahimi, R. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_8 · Cited by 7
Rider, V., Thomson, E., & Seifert, C. (2003) · Endocrinology · doi:10.1210/en.2003-0890 · Cited by 7
Plourde, M., Samson, C., Durocher, F., Sinilnokova, O., & Simard, J. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.10.004 · Cited by 9
Sierralta, W. D., EPUÑÁN, M. J., Reyes, J. M., Valladares, L., & Pino, A. M. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-69080-3_45 · Cited by 7
Tipbunjong, C., Khimmaktong, W., Hengpratom, T., Thitiphatphuvanon, T., Pholpramool, C., & Surinlert, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072949 · Cited by 6
Häger, A., Kondle, S., Agarwal, A., Chintapenta, M., Horadam, R., Sadeghi, N., & Syed, S. K. (2024) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552241232692 · Cited by 6
Akman, T., Arendt, L. M., Geisler, J., Kristensen, V. N., Frigessi, A., & Köhn‐Luque, A. (2024) · Bulletin of Mathematical Biology · doi:10.1007/s11538-023-01253-1 · Cited by 7
Subramanyan, L. V., Rasheed, S. A. K., Wang, L., Ghosh, S., Ong, M. S., Lakshmanan, M., Wang, M., & Casey, P. J. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01866-x · Cited by 9
Cellular Mechanisms of Oestrogen in Breast Cancer Development
Awolaran, O. (2015) · The Open Access Journal of Science and Technology · doi:10.11131/2015/101131 · Cited by 8
Urbinati, G., Marsaud, V., Nicolas, V., Vergnaud, J., & Renoir, J. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2011.005 · Cited by 6
Liu, Y.-S. (2015) · The Chinese Journal of Physiology · doi:10.4077/cjp.2015.bac239 · Cited by 6
Guo, L. Y., Li, F., Wang, M., Xu, Y., Wang, B., Ran, D., & Zhang, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.7796 · Cited by 7
PTHrP inhibits BMP-6 expression through the PKA signaling pathway in breast cancer cells
Mi, D., Zhang, M., Yan, J.-D., Zhang, J., Wang, X., Wang, Q., Yang, S., & Zhu, T.-H. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0883-y · Cited by 6
Romero-Arias, J. R., González-Castro, C. A., & Ramírez-Santiago, G. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011673 · Cited by 6
Nicolini, A., Rossi, G., & Ferrari, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1225175 · Cited by 6
He, W., Shajahan‐Haq, A. N., & Baumann, W. T. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3008-2_16 · Cited by 5
Jung, S. Y., Yu, H., Deng, Y., & Pellegrini, M. A. (2024) · Aging · doi:10.18632/aging.206169 · Cited by 5
Hormonal and Targeted Treatments in Breast Cancer
Kumar, S., Gupta, S., Maurya, A. P., Rajender, S., & Nigam, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-4546-4_21 · Cited by 5
Toker, P., Ayten, H., Demiralay, Ö. D., Bınarcı, B., Turan, G., Olgun, Ç. E., Yaşar, P., Akman, H. B., & Muyan, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-90456-8 · Cited by 5
Zhao, H. W., Yu, J. J., Peltier, C. P., & Davie, J. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20218 · Cited by 5
Arvelo, F. A., Sojo, F. J., & Cotte, C. (2021) · Investigación Clínica · doi:10.22209/ic.v62n4a09 · Cited by 5
Lian, J. B., & Stein, G. S. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50008-2 · Cited by 9
Ansari, S., Purohit, K. J., Shelke, A. B., Shah, M., Nkhoma, I. A., Navale, A. M., & Wakchaure, R. S. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02296-9 · Cited by 4
A mathematical model for pancreatic cancer during intraepithelial neoplasia
Briones-Andrade, J., Ramírez-Santiago, G., & Romero-Arias, J. R. (2024) · Royal Society Open Science · doi:10.1098/rsos.240702 · Cited by 4
McGlacken-Byrne, S. M., del Valle, I., Xenakis, T., Suntharalingham, J. P., Nel, L., Liptrot, D., Crespo, B., Ogunbiyi, O. K., Niola, P., Brooks, T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.22.572342 · Cited by 4
Alballa, T., Zarin, R., ZEB, A., Khan, A., Khalifa, H. A. E., & Humphries, U. W. (2025) · Fractals · doi:10.1142/s0218348x25401735 · Cited by 3
Lee, K., Yoo, J. E., Nguyen, T. L., Hopper, J. L., & Song, Y. (2018) · Hormones and Cancer · doi:10.1007/s12672-018-0344-7 · Cited by 3
Oelschläger, L., Stahl, P., Kaschani, F., Stauber, R. H., Knauer, S. K., & Hensel, A. (2023) · Cells · doi:10.3390/cells12030363 · Cited by 4
Hormone Action and Breast Cancer
Levin, E. R. (2008) · Cancer treatment and research · doi:10.1007/978-0-387-09463-2_3 · Cited by 3
Pratama, N. R., Gilang, Y., Riata, R., Hermawan, A., Ikawati, M., & Meiyanto, E. (2011) · Indonesian Journal of Cancer Chemoprevention · doi:10.14499/indonesianjcanchemoprev2iss1pp151-158 · Cited by 3
Islam, M. A., Patel, D. A., Rathod, S. G., Patil, P. C., & Pillay, T. S. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-015-1496-4 · Cited by 3
Khalifa, S., Ismail, A., Saied, E. M., & El-Tamamy, M. (2018) · Kasr Al Ainy Medical Journal · doi:10.4103/kamj.kamj_31_17 · Cited by 5
Size, site, and signaling: Three attributes of estrogen receptors
Sachdeva, G., Desouza, J., Gadkar, S., & Jagtap, D. D. (2019) · Biomedical Research Journal · doi:10.4103/bmrj.bmrj_24_19 · Cited by 5
dos Santos, A. P. S. D. A. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2010.tde-13122010-112823 · Cited by 7
Cell Cycle Genes in a Mouse Mammary Hyperplasia Model
Said, T. K., & Medina, D. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000023590.63974.f8 · Cited by 3
Rigassi, L., Rosselli, M., Leeners, B., Popa, M. A., & Dubey, R. K. (2025) · Cells · doi:10.3390/cells14151132 · Cited by 2
Mammary Gland Microbiota in Benign Breast Diseases
Ukraincev, N. I., Kashutina, M. I., Касаткина, Л. И., Бахтиерович, А. А., & Zhernov, Y. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209951 · Cited by 2
Devakrishnan, A. K., Madasu, C., Wang, Y., Modukuri, R. K., Bohren, K. M., MacKenzie, K. R., Young, D. W., Fuqua, S. A. W., Matzuk, M. M., & Palaniappan, M. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00837-5 · Cited by 3
Leclercq, G. (2020) · Endocrines · doi:10.3390/endocrines2010001 · Cited by 2
Narayan, S. S., Vaishnaw, N. S., Shivakumar, B. N., & Vaishnav, A. (2022) · Journal of Physics Conference Series · doi:10.1088/1742-6596/2332/1/012020 · Cited by 2
Altered hormone expression induced genetic changes leads to breast cancer
Thakur, A., Rana, N., & Kumar, R. (2024) · Current Opinion in Oncology · doi:10.1097/cco.0000000000001019 · Cited by 5
G1 Phase Cyclins in Cancer Development and Progression
Alao, J. P. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_9 · Cited by 2
A Mathematical Model of In Vitro Estrogen-Related Cancer Cell Growth Based on Cell-Cycle Mechanism
Ibrahim, F., Huang, B., Xing, J. Z., Roa, W., & Gabos, S. (2010) · IFAC Proceedings Volumes · doi:10.3182/20100707-3-be-2012.0039 · Cited by 2
Todorović‐Raković, N., Milovanović, J., Durosaro, S. O., & Radulović, M. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153430 · Cited by 2
Lian, J. B., & Stein, G. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50007-x · Cited by 4
Estrogen Receptors and Anti-Estrogen Therapies
Buluwela, L., Constantinidou, D., Pike, J., & Ali, S. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7847-1_13 · Cited by 2
Steroid receptor coactivators: from basic research to translational opportunities
Gilad, Y., Han, S. J., & Lonard, D. M. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag003 · Cited by 2
Somatic Alterations and Implications in Breast Cancer
Ton, C. C. T., Guenthoer, J., & Porter, P. L. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0477-5_9 · Cited by 1
Kim, T. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.738 · Cited by 1
Estrogens, Cell Proliferation and Breast Cancer
Sutherland, R. L., Sergio, C. M., McNeil, C., Anderson, L. R., Inman, C. K., Butt, A. J., & Musgrove, E. A. (2007) · Springer eBooks · doi:10.1007/978-3-540-73855-8_12 · Cited by 1
Self-citationVoňka, P., Rárová, L., Bazgier, V., Tichý, V., Kolářová, T., Holčáková, J., Berka, K., Kvasnica, M., Oklešťková, J., Kudová, E., et al. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106365 · Cited by 1
Mechanisms of development and the ways to overcome endocrine resistance in breast cancer
Khisamov, A. A., Olga, M., & Byakhov, M. (2015) · Malignant tumours · doi:10.18027/2224-5057-2015-4-52-61 · Cited by 2
Rau, K.-M., Day, C., & Hung, M. (2007) · Springer eBooks · doi:10.1007/978-3-540-28266-2_34 · Cited by 2
Campi, V. (2007) · KOPS (University of Konstanz) · Cited by 1
MicroRNAs Contribute to the Protective Actions of 17β-Estradiol on the Vascular System
Rigassi, L. (2016) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-010737742 · Cited by 1
Lemieux, C. (2005) · Corpus Université Laval (Université Laval) · Cited by 3
Effect of O-GlcNAcylation on tamoxifen sensitivity in breast cancer derived MCF-7 cells
Kanwal, S. (2013) · theses.fr (ABES) · doi:10.70675/9d4494d5zfd67z41e8z8d15z047b7f7f76ba · Cited by 5
Endometrial maturation: the role of oestradiol and progesterone
Dassen, H. H. N. M. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20111104hd · Cited by 1
Aaltonen, K. (2008) · Helda - University of Helsinki Institutional Repository
Proteomics of invasiveness of human breast epithelial cells
Lin, K. W. (2012) · Figshare
Garcia, S. A. D. B. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2009.tde-30042010-093125 · Cited by 1
Clinical potential of the mTOR effectors S6K1, S6K2 and 4EBP1 in breast cancer
Karlsson, E. A. (2014) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-104180
Molecular characterization of estrogen receptors with focus on breast cancer
Putnik, M. (2012) · Figshare
Customization of tamoxifen therapy : not only a dream
Sanchez, B. C. (2011) · Figshare
AIB1: A Transcriptional Coactivator Which Integrates Signaling Cross Talk in Cancer Cells
Ferrero, M., & de Mora, J. F. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0730-0_7
Carreau, C. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Metadata
- Authors
- Doisneau-Sixou, S. F., Sergio, C. M., Carroll, J. S., Hui, R., Musgrove, E. A., & Sutherland, R. L.
- Affiliations
- Garvan Institute of Medical Research (AU)
- Corresponding author
- Sutherland, R L
- Venue
- Endocrine Related Cancer
- Publisher
- Bioscientifica
- Published
- 2003-06-01
- Volume
- 10
- Issue
- 2
- Pages
- 179-186
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2121155074
- Cited by
- 333
- References
- 53
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 12 · 2023: 16 · 2022: 17 · 2021: 15 · 2020: 8 · 2019: 8 · 2018: 14 · 2017: 9 · 2016: 15 · 2015: 13 · 2014: 17 · 2013: 7 · 2012: 9
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Related Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- National Health and Medical Research Council
- Cancer Council NSW
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- estrogen, antiestrogens, breast cancer, cell cycle progression, c-Myc, cyclin D1, p21, cyclin E/CDK2, G1/S phase, MCF-7 cells, quiescence, carcinogenesis, cyclin-dependent kinase inhibitors
- MeSH terms
- Animals, Breast Neoplasms, Cell Cycle, Estrogens, Female, Humans, Cyclins, Proto-Oncogene Proteins c-myc, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinases, Cyclin E, Cyclin D1, Estrogen Receptor Modulators, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.